Life Science Real Estate: Public vs. Private Marks Diverge
Life Science Real Estate: Public vs. Private Marks Diverge
September 25, 2025
Private Credit: Generational Opportunity or Looming Implosion?
Private Credit: Generational Opportunity or Looming Implosion?
September 24, 2025
Debt Pressures, Dollar Doubts: CRE and the Reserve Currency Question
Debt Pressures, Dollar Doubts: CRE and the Reserve Currency Question
September 24, 2025
Lehman’s Archstone Deal: How a $22B LBO Shook Wall Street
Lehman’s Archstone Deal: How a $22B LBO Shook Wall Street
September 19, 2025
Lehman’s $22B Archstone Deal: The Bet That Broke a Bank
Lehman’s $22B Archstone Deal: The Bet That Broke a Bank
September 19, 2025
AI Boom or Bubble? Market Bets vs. Real Returns
AI Boom or Bubble? Market Bets vs. Real Returns
September 15, 2025
New York vs. Texas: The Battle for Finance Jobs
New York vs. Texas: The Battle for Finance Jobs
September 8, 2025
Apollo’s $1.5B Bridge Deal: Track Record or Growth Play?
Apollo’s $1.5B Bridge Deal: Track Record or Growth Play?
September 5, 2025
Core vs. Core Plus: Why Investors Favor Higher-Return Real Estate Funds
Core vs. Core Plus: Why Investors Favor Higher-Return Real Estate Funds
September 3, 2025
Goldman Sachs: CRE on Firmer Footing but Facing a New Normal
Goldman Sachs: CRE on Firmer Footing but Facing a New Normal
September 2, 2025
Office Real Estate’s Biggest Problem: It’s Not Occupancy, It’s Capex
Office Real Estate’s Biggest Problem: It’s Not Occupancy, It’s Capex
September 2, 2025
Paramount Group: Why an Office REIT Buyout Looks Likely
Paramount Group: Why an Office REIT Buyout Looks Likely
September 2, 2025